Mediclinic International plc (Incorporated in England and Wales) Company Number: 08338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

South African income tax number: 9432434182 ('Mediclinic', the 'Company', or the 'Group')

16 August 2022

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00B8HX8Z88

Issuer Name

MEDICLINIC INTERNATIONAL PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation Name

JPMorgan Chase & Co.

City of registered office (if applicable)

Country of registered office (if applicable)

US

4. Details of the shareholder

Name

City of registered office

Country of registered office

J.P. Morgan Securities plc

  1. Date on which the threshold was crossed or reached 11-Aug-2022
  2. Date on which Issuer notified

15-Aug-2022

7. Total positions of person(s) subject to the notification obligation

.

% of voting

% of voting rights

Total of both

Total number

rights attached

through financial

in % (8.A +

of voting rights

to shares (total

instruments (total

8.B)

held in issuer

of 8.A)

of 8.B 1 + 8.B 2)

Resulting situation

2.909403

4.879603

7.789006

57424507

on the date on

which threshold

was crossed or

reached

Position of

2.338777

4.882364

7.221141

previous

notification (if

applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of

Number of direct

Number of indirect

% of direct

% of indirect

shares ISIN

voting rights

voting rights

voting rights

voting rights

code(if possible)

(DTR5.1)

(DTR5.2.1)

(DTR5.1)

(DTR5.2.1)

GB00B8HX8Z88

21449768

2.909403

Sub Total 8.A

21449768

2.909403%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial

Expiration

Exercise/conversion

Number of voting rights that

% of

instrument

date

period

may be acquired if the

voting

instrument is

rights

exercised/converted

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of

Expiration date

Exercise/conversion

Physical or

Number of

% of voting

financial

period

cash

voting rights

rights

instrument

settlement

Cash-

23/11/2022

23/11/2022

Cash

28558635

3.873700

settled

Equity

Swap

Cash-

01/02/2023

01/02/2023

Cash

16152

0.002190

settled

Equity

Swap

Cash-

22/02/2023

22/02/2023

Cash

9795

0.001328

settled

Equity

Swap

Cash-

02/06/2023

02/06/2023

Cash

143409

0.019451

settled

Equity

Swap

Cash-

04/07/2023

04/07/2023

Cash

7146094

0.969293

settled

Equity

Swap

Cash-

12/07/2023

12/07/2023

Cash

12885

0.001745

settled

Equity

Swap

Cash-

09/08/2023

09/08/2023

Cash

759

0.000102

settled

Equity

Swap

Cash-

16/08/2023

16/08/2023

Cash

4600

0.000623

settled

Equity

Swap

Cash-

21/08/2023

21/08/2023

Cash

526

0.000070

settled

Equity

Swap

Cash-

22/08/2023

22/08/2023

Cash

598

0.000081

settled

Equity

Swap

Cash-

06/07/2027

06/07/2027

Cash

309

0.000041

settled

Equity

Swap

Cash-

03/08/2027

03/08/2027

Cash

289

0.000038

settled

Equity

Swap

Cash-

09/07/2029

09/07/2029

Cash

65281

0.008853

settled

Equity

Swap

Cash-

12/02/2024

12/02/2024

Cash

1612

0.000218

settled

Equity

Swap

Cash-

06/09/2023

06/09/2023

Cash

13795

0.001870

settled

Equity

Swap

Sub Total 8.B2

35974739

4.879603%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate

Name of controlled

% of voting

% of voting rights

Total of both if it

controlling person

undertaking

rights if it

through financial

equals or is higher

equals or is

instruments if it

than the notifiable

higher than

equals or is higher

threshold

the notifiable

than the notifiable

threshold

threshold

JPMorgan

J.P. Morgan

4.879603

6.033195%

Chase & Co.

Securities plc

JPMorgan

JPMorgan

Chase & Co.

Chase Bank,

National

Association

JPMorgan

J.P. Morgan

Chase & Co.

Equities

South Africa

Proprietary

Limited

JPMorgan

J.P. Morgan

Chase & Co.

Securities

LLC

10. In case of proxy voting Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information Chain of controlled undertakings:

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%)

J.P. Morgan International Finance Limited (100%)

J.P. Morgan Capital Holdings Limited (100%)

J.P. Morgan Securities plc (100%)

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%)

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%) J.P. Morgan International Finance Limited (100%) J.P. Morgan Capital Holdings Limited (100%)

J.P. Morgan Equities South Africa Proprietary Limited (100%)

JPMorgan Chase & Co.

JPMorgan Chase Holdings LLC (100%)

J.P. Morgan Broker-Dealer Holdings Inc. (100%)

J.P. Morgan Securities LLC (100%)

  1. Date of Completion
    15-Aug-2022
  2. Place Of Completion London

About Mediclinic International plc

Mediclinic is a diversified international private healthcare services group, established in South Africa in 1983, with divisions in Switzerland, Southern Africa (South Africa and Namibia) and the Middle East.

The Group's core purpose is to enhance the quality of life.

Its vision is to be the partner of choice that people trust for all their healthcare needs.

Mediclinic is focused on providing specialist-orientated,multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets.

At 30 June 2022, Mediclinic comprised 74 hospitals, five subacute hospitals, two mental health facilities, 20 day case clinics and 23 outpatient clinics. The Swiss operations included 17 hospitals and four day case clinics with around 1 900 inpatient beds; Southern Africa operations included 50 hospitals (three of which in Namibia), five subacute hospitals, two mental health facilities and 14 day case clinics (four of which operated by Intercare) across South Africa, and around 8 650 inpatient beds; and the Middle East operated seven hospitals, two day case clinics and 23 outpatient clinics with around 1 000 inpatient

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Mediclinic International plc published this content on 16 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 August 2022 10:33:12 UTC.